Fiche centre
Tianjin Medical University General Hospital
Tianjin — China
Essais liés18clinical trials
VilleTianjinlocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06875310
Essais cliniques associés
18| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis | Alzheimer | À vérifier | NCT07232459 | [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis | RECRUITING |
| Beta Amyloid PET/CT in Various Aβ-Related Disease | Alzheimer | À vérifier | NCT06725706 | Beta Amyloid PET/CT in Various Aβ-Related Disease | RECRUITING |
| Pan-Amyloid PET/CT in Various Amyloid-Related Disease | Alzheimer | À vérifier | NCT07130565 | Pan-Amyloid PET/CT in Various Amyloid-Related Disease | RECRUITING |
| [18F]NIDF PET Imaging in Tau-related Diseases | Alzheimer | À vérifier | NCT07306598 | [18F]NIDF PET Imaging in Tau-related Diseases | RECRUITING |
| Alpha-Synuclein PET/CT in Various α-Syn-Related Disease | Parkinson | À vérifier | NCT06949670 | Alpha-Synuclein PET/CT in Various α-Syn-Related Disease | RECRUITING |
| Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease | Parkinson | À vérifier | NCT07685873 | Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease | RECRUITING |
| Cizutamig | Myasthénie | Phase 1 | NCT07215650 | Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG) | RECRUITING |
| Cizutamig | Lupus | Phase 1 | NCT07215663 | Clinical Study of Cizutamig in Systemic Lupus Erythematosus | RECRUITING |
| Amivantamab | Cancer | Phase 3 | NCT04538664 | PAPILLON — A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions | ACTIVE_NOT_RECRUITING |
| M5049 low dose | Lupus | Phase 2 | NCT05540327 | The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) | ACTIVE_NOT_RECRUITING |
| Galcanezumab | Migraine | Phase 3 | NCT03963232 | PERSIST — A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine | COMPLETED |
| Adagrasib | Cancer | Phase 3 | NCT06875310 | A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4) | RECRUITING |
| Trontinemab | Alzheimer | Phase 3 | NCT07169578 | TRONTIER 1 — A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | RECRUITING |
| Donanemab | Alzheimer | Phase 3 | NCT07571161 | Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease | RECRUITING |
| Prasinezumab | Parkinson | Phase 3 | NCT07174310 | PARAISO — A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease | RECRUITING |
| Pozelimab + Cemdisiran | Myasthénie | Phase 3 | NCT05070858 | NIMBLE — A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis | ACTIVE_NOT_RECRUITING |
| Nipocalimab | Myasthénie | Phase 3 | NCT04951622 | A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | RECRUITING |
| Fenebrutinib | SEP | Phase 3 | NCT04586010 | FENhance — A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) | ACTIVE_NOT_RECRUITING |